Inslee announces unprecedented state purchase of three-year supply of mifepristone
Story
Governor joins legislators and AG Ferguson in committing to protect access to medical abortion
Gov. Jay Inslee today announced that Washington state has taken unprecedented action to purchase a three-year supply of mifepristone, an abortion medication used safely for more than two decades. Inslee directed the state Department of Corrections, using its existing pharmacy license, to purchase the medication last month. The full shipment was delivered on March 31.
Inslee was joined at a press conference today by legislators who are introducing legislation authorizing the state Department of Corrections to distribute or sell the medication to licensed health providers across the state, and by Attorney General Bob Ferguson who is helping lead a multi-state lawsuit aiming to protect access to the medication.
Governor joins legislators and AG Ferguson in committing to protect access to medical abortion
Gov. Jay Inslee today announced that Washington state has taken unprecedented action to purchase a three-year supply of mifepristone, an abortion medication used safely for more than two decades. Inslee directed the state Department of Corrections, using its existing pharmacy license, to purchase the medication last month. The full shipment was delivered on March 31.
Inslee was joined at a press conference today by legislators who are introducing legislation authorizing the state Department of Corrections to distribute or sell the medication to licensed health providers across the state, and by Attorney General Bob Ferguson who is helping lead a multi-state lawsuit aiming to protect access to the medication.
Media Contact
Public and constituent inquiries | 360.902.4111
Press inquiries | 360.902.4136
Public and constituent inquiries | 360.902.4111
Press inquiries | 360.902.4136
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
